Posted: Noviembre 4, 2019
A recent publication described some aspects of the interaction between cannabidiol
and the antiepileptic drug clobazam. But they’re a little late to the game.
Posted: Octubre 29, 2019
CBD has shown some promise in anxiety and panic disorders, from public speaking to schizophrenia. A group of London researchers followed up on these results with an experiment published in the Journal of Psychopharmacology.
Posted: Octubre 21, 2019
Confused about cannabis
addiction and withdrawal? So are the experts. Researchers were recently surprised to find that cannabis use was not well correlated with its own supposed withdrawal syndrome.
Posted: Octubre 18, 2019
Compounds from nutmeg, a spice already well-known for its hallucinogenic effects at high doses, may also interact with our endocannabinoid systems.
Posted: Octubre 3, 2019
“[T]he degree of impairment resulting from recent cannabis use is difficult to distinguish from other conditions such as advancing age or use of certain medications,” according to a review in The American Journal of Drug and Alcohol Abuse. It begs the question of why cannabis should be treated differently.
Posted: Octubre 2, 2019
A recent analysis examined the incidences of fatal car crashes in the five years before and after cannabis
legalization in Colorado and Washington.
Posted: Octubre 1, 2019
After over a century of failing to find a causal link between cannabis use and schizophrenia, proponents of Reefer Madness have had to couch their warnings.
Posted: Septiembre 30, 2019
Scientists examined how savoring positive experiences predicts aspects of problematic cannabis use, but the numbers don’t add up.
Posted: Septiembre 25, 2019
Evidence is accumulating that the endocannabinoid system contributes significantly to the so-called «runner’s high.»
Posted: Septiembre 24, 2019
Cannabinoids seem promising for treating the symptoms or progression of rheumatoid arthritis. A new controlled trial seeks to study CBD and THC“s impacat on arthritic pain.
Posted: Septiembre 23, 2019
Brazilian researchers looked into CBD“s health effects in an animal model of diabetic brain damage due to oxygen deprivation and found promising results.
Posted: Septiembre 20, 2019
β-caryophyllene (BCP) is a terpene present in cannabis as well as many dark green, leafy vegetables. This CB2 activator could be beneficial in treating many problems associated with type 2 diabetes.
Posted: Septiembre 12, 2019
It is increasingly recognized that cannabidiol can moderate many of the effects of THC, but the mechanisms by which CBD does this aren’t obvious. The neurotransmitter adenosine may be one important link.
Posted: Septiembre 12, 2019
Some research has shown that caffeine can amplify the short-term forgetfulness caused by THC. A new study indicates that the caffeine may block other effect of cannabinoids.
Posted: Septiembre 11, 2019
Dosing CBD and other cannabinoids is challenging. An article in Molecules detailed the absorption and kinetics of a new formulation of self-emulsifying CBD.
Posted: Septiembre 10, 2019
Researchers from eight different countries recently collaborated on an article warning about the dangers of teens falling in love.
Posted: Septiembre 9, 2019
The protective effect of cannabinoids for those living with Type 2 diabetes and obesity is particularly pronounced among people with schizophrenia. Why?
Posted: Julio 23, 2019
A recent study from pharmacologists at the University of Minnesota examined how eating a meal affects the absorption of CBD.
Posted: Julio 20, 2019
One broad effect of CBD and THC is the stimulation of neurogenesis — the production and integration of new neurons in the brain. Researchers in Barcelona, Spain, recently studied how CBD would affect addiction and learning in mice when neurogenesis was artificially prevented.
Posted: Julio 16, 2019
Recent research has indicated a role of endocannabinoids in endometriosis and related diseases. A study published in Frontiers in Oncology sought to determine whether endometrial cancer could be predicted by someone’s levels of the two canonical cannabinoid receptors (CB1 and CB2) and three related fatty acids (anandamide, OEA, and PEA).